Spyre Therapeutics Inc (SYRE)

Total Costs & Expenses

$41.64M

Quarterly · Period ending: · USD

SYRE logo

SYRE Total Costs & Expenses

Latest reported$41.64M
SYRE Quarterly Total Costs & Expenses ($857.00K → $41.64M)
High-resolution chart · PNG

SYRE total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
41,639,000
45,641,000
147,666,000
56,888,000
41,935,000
53,567,000
61,253,000
55,392,000
44,147,000
47,774,000
45,914,000
18,337,000
159,934,000
19,004,000
19,330,000
18,929,000
23,048,000
25,803,000
24,086,000
21,692,000
20,401,000
18,209,000
22,776,000
18,123,000
21,560,000
19,022,000
21,909,000
22,146,000
18,622,000
17,657,000
15,305,000
12,243,000
12,048,000
9,755,000
8,108,000
9,259,000
8,199,000
7,313,000
6,790,000
7,450,000
6,868,000
5,426,000
5,582,000
4,490,000
4,859,000
2,469,000
3,181,000
3,140,000
1,726,000
857,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.